Literature DB >> 27287542

The incretin hormone GLP-1 and mechanisms underlying its secretion.

Lili Tian1,2,3, Tianru Jin4,5,6.   

Abstract

Glucagon-like peptide-1 (GLP-1) is a cell type-specific post-translational product of proglucagon. It is encoded by the proglucagon gene and released primarily from intestinal endocrine L-cells in response to hormonal, neuronal, and nutritional stimuli. In addition to serving as an incretin in mediating the effect of meal consumption on insulin secretion, GLP-1 exerts other functions in pancreatic islets, including regulation of β-cell proliferation and protection of β-cells against metabolic stresses. Furthermore, GLP-1 exerts numerous other functions in extrapancreatic organs, whereas brain GLP-1 signaling controls satiety. Herein we review the discovery of two incretins and the development of GLP-1-based drugs. We also describe the development of cellular models for studying mechanisms underlying GLP-1 secretion over the past 30 years. However, the main content of this review is a summary of studies on the exploration of mechanisms underlying GLP-1 secretion. We not only summarize studies conducted over the past three decades on elucidating the role of nutritional components and hormonal factors in regulating GLP-1 secretion, but also present a few very recent studies showing the possible role of dietary polyphenols. Finally, the emerging role of gut microbiota in metabolic homeostasis with the potential implication on GLP-1 secretion is discussed.
© 2016 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  L-cell models; L细胞模型; hormone secretion; incretins; microbiota; short-chain fatty acids; 微生物; 激素分泌; 短链脂肪酸; 肠促胰岛素

Mesh:

Substances:

Year:  2016        PMID: 27287542     DOI: 10.1111/1753-0407.12439

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  18 in total

1.  [Effect of glucagon-like peptide 1 receptor agonists on body fat redistribution and muscle mass in overweight and obese type 2 diabetic patients].

Authors:  Yudan Zhang; Shiqun Liu; Cunxia Fan; Yanmei Zeng; Jimin Li; Cuihua Xie; Yaoming Xue; Meiping Guan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-04-30

Review 2.  Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management.

Authors:  Alexandra Jichitu; Simona Bungau; Ana Maria Alexandra Stanescu; Cosmin Mihai Vesa; Mirela Marioara Toma; Cristiana Bustea; Stela Iurciuc; Marius Rus; Nicolae Bacalbasa; Camelia Cristina Diaconu
Journal:  Diagnostics (Basel)       Date:  2021-04-12

3.  Dietary Gamma-Aminobutyric Acid (GABA) Induces Satiation by Enhancing the Postprandial Activation of Vagal Afferent Nerves.

Authors:  Utano Nakamura; Taichi Nohmi; Riho Sagane; Jun Hai; Kento Ohbayashi; Maiko Miyazaki; Atsushi Yamatsu; Mujo Kim; Yusaku Iwasaki
Journal:  Nutrients       Date:  2022-06-16       Impact factor: 6.706

4.  [Exendin-4 alleviates diabetic cardiomyopathy in mice by regulating Sirt1/PGC1α].

Authors:  Ying-Ying Cai; Shao-Zhou Zou; Cun-Xia Fan; Chun-Yan Wu; Shu Fang; Ping Li; Yao-Ming Xue; Mei-Ping Guan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-05-20

Review 5.  Cellular signaling pathways regulating β-cell proliferation as a promising therapeutic target in the treatment of diabetes.

Authors:  Wen-Juan Jiang; Yun-Chuan Peng; Kai-Ming Yang
Journal:  Exp Ther Med       Date:  2018-08-13       Impact factor: 2.447

6.  Alteration of GLP-1/GPR43 expression and gastrointestinal motility in dysbiotic mice treated with vancomycin.

Authors:  Xin Xu; Hirokazu Fukui; Ying Ran; Toshihiko Tomita; Tadayuki Oshima; Jiro Watari; Hiroto Miwa
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

7.  Gastrointestinal Distension by Pectin-Containing Carbonated Solution Suppresses Food Intake and Enhances Glucose Tolerance via GLP-1 Secretion and Vagal Afferent Activation.

Authors:  Kento Ohbayashi; Yukiko Oyama; Chiharu Yamaguchi; Toshiki Asano; Toshihiko Yada; Yusaku Iwasaki
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-08       Impact factor: 5.555

8.  Combined Oral Administration of GABA and DPP-4 Inhibitor Prevents Beta Cell Damage and Promotes Beta Cell Regeneration in Mice.

Authors:  Wenjuan Liu; Dong Ok Son; Harry K Lau; Yinghui Zhou; Gerald J Prud'homme; Tianru Jin; Qinghua Wang
Journal:  Front Pharmacol       Date:  2017-06-20       Impact factor: 5.810

Review 9.  Brain metabolic sensing and metabolic signaling at the level of an astrocyte.

Authors:  Nephtali Marina; Egor Turovsky; Isabel N Christie; Patrick S Hosford; Anna Hadjihambi; Alla Korsak; Richard Ang; Svetlana Mastitskaya; Shahriar Sheikhbahaei; Shefeeq M Theparambil; Alexander V Gourine
Journal:  Glia       Date:  2017-12-23       Impact factor: 8.073

10.  Internalization-Dependent Free Fatty Acid Receptor 2 Signaling Is Essential for Propionate-Induced Anorectic Gut Hormone Release.

Authors:  Natarin Caengprasath; Noemi Gonzalez-Abuin; Maria Shchepinova; Yue Ma; Asuka Inoue; Edward W Tate; Gary Frost; Aylin C Hanyaloglu
Journal:  iScience       Date:  2020-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.